LiteFold/IEDB huggingface dataset:
Reference: M L Zhao; R B Fritz. "The immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra- and intermolecular dominant epitopes." Journal of neuroimmunology (1995).

Epitope: MBP pAc1-11
Chemical type: Peptide from protein
Sequence: ASQKRPSQRHG
Position: 2-12
Source molecule (GenBank): CAA10806.1
Assay category: TCell
Result: Positive
Host: F 6-10 weeks
Cell type: lymph node cells
Tissue: lymph node
Culture conditions: Short Term Restimulated

Epitope: MBP pAc1-11
Chemical type: Peptide from protein
Sequence: ASQKRPSQRHG
Position: 2-12
Source molecule (GenBank): CAA10806.1
Assay category: TCell
Result: Negative
Host: F 6-10 weeks

Epitope: MBP 43-88
Chemical type: Peptide from protein
Sequence: RFFSGDRGAPKRGSGKDSHTRTTHYGSLPQKSQRTQDENPVV
Position: 44-85
Source molecule (GenBank): CAA10806.1
Assay category: TCell
Result: Positive
Host: F 6-10 weeks
Cell type: lymph node cells
Tissue: lymph node
Culture conditions: Short Term Restimulated

Epitope: MBP 89-101
Chemical type: Peptide from protein
Sequence: VHFFKNIVTPRTP
Position: 85-97
Source molecule (GenBank): CAA10806.1
Assay category: TCell
Result: Positive
Host: F 6-10 weeks
Cell type: lymph node cells
Tissue: lymph node
Culture conditions: Short Term Restimulated

Epitope: PLP 139-151
Chemical type: Peptide, no natural source
Sequence: HSLGKWLGHPDKF
Assay category: TCell
Result: Positive
Host: F 6-10 weeks
Cell type: lymph node cells
Tissue: lymph node
Culture conditions: Short Term Restimulated

Epitope: PLP 139-151
Chemical type: Peptide, no natural source
Sequence: HSLGKWLGHPDKF
Assay category: TCell
Result: Positive
Host: F 6-10 weeks
Reference: M F Samson; D E Smilek. "Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes." Journal of immunology (Baltimore, Md. : 1950) (1995).

Epitope: MBP Ac1-11
Chemical type: Peptide from protein
Sequence: ASQKRPSQRHG
Position: 2-12
Source molecule (GenBank): CAA10806.1
Assay category: TCell
Result: Negative
Host:  8-14 weeks
Cell type: lymphocyte
Tissue: lymph node
Culture conditions: Direct Ex Vivo

Epitope: MBP Ac1-11
Chemical type: Peptide from protein
Sequence: ASQKRPSQRHG
Position: 2-12
Source molecule (GenBank): CAA10806.1
Assay category: TCell
Result: Positive
Host:  8-14 weeks

Epitope: MBP Ac1-11
Chemical type: Peptide from protein
Sequence: ASQKRPSQRHG
Position: 2-12
Source molecule (GenBank): CAA10806.1
Assay category: TCell
Result: Positive-Low
Host:  8-14 weeks
Cell type: lymphocyte
Tissue: lymph node
Culture conditions: Direct Ex Vivo

Epitope: MBP Ac1-11[4Y]
Chemical type: Peptide, no natural source
Sequence: ASQYRPSQRHG
Assay category: TCell
Result: Positive
Host:  8-14 weeks

Epitope: MBP Ac1-11[4Y]
Chemical type: Peptide, no natural source
Sequence: ASQYRPSQRHG
Assay category: TCell
Result: Positive
Host: F 
Cell type: T cell hybridoma
Tissue: lymph node
Culture conditions: Cell Line / Clone

Epitope: MBP Ac1-11[4Y]
Chemical type: Peptide, no natural source
Sequence: ASQYRPSQRHG
Assay category: TCell
Result: Positive-Low
Host:  8-14 weeks
Cell type: lymphocyte
Tissue: lymph node
Culture conditions: Direct Ex Vivo

Epitope: MBP Ac1-11[4Y]
Chemical type: Peptide, no natural source
Sequence: ASQYRPSQRHG
Assay category: TCell
Result: Negative
Host:  8-14 weeks
Cell type: lymphocyte
Tissue: lymph node
Culture conditions: Direct Ex Vivo

Epitope: MBP Ac1-11[4Y]
Chemical type: Peptide, no natural source
Sequence: ASQYRPSQRHG
Assay category: TCell
Result: Negative
Host:  8-14 weeks
Cell type: lymphocyte
Tissue: lymph node
Culture conditions: Direct Ex Vivo
Reference: R Zeine; D Heath; T Owens. "Enhanced response to antigen within lymph nodes of SJL/J mice that were protected against experimental allergic encephalomyelitis by T cell vaccination." Journal of neuroimmunology (1993).

Epitope: MBP 90-99
Chemical type: Peptide from protein
Sequence: FKNIVTPRTP
Position: 89-98
Source molecule (GenBank): P25188.1
Assay category: TCell
Result: Positive
Host: F 4-8 weeks

Epitope: MBP 90-99
Chemical type: Peptide from protein
Sequence: FKNIVTPRTP
Position: 89-98
Source molecule (GenBank): P25188.1
Assay category: TCell
Result: Positive-High
Host: F 4-8 weeks
Cell type: lymph node cells
Tissue: lymph node
Culture conditions: Short Term Restimulated

Epitope: MBP 90-99
Chemical type: Peptide from protein
Sequence: FKNIVTPRTP
Position: 89-98
Source molecule (GenBank): P25188.1
Assay category: TCell
Result: Positive
Host: F 4-8 weeks
Cell type: T cell CD4+
Tissue: lymph node
Culture conditions: Cell Line / Clone

Epitope: PLP  91-102
Chemical type: Peptide from protein
Sequence: FKNIVTPRTPPP
Position: 114-125
Source molecule (GenBank): AAB59711.1
Assay category: TCell
Result: Positive
Host: F 4-8 weeks
Cell type: lymph node cells
Tissue: lymph node
Culture conditions: Short Term Restimulated

Epitope: PLP 139-151
Chemical type: Peptide, no natural source
Sequence: HSLGKWLGHPDKF
Assay category: TCell
Result: Positive
Host: F 4-8 weeks
Cell type: lymph node cells
Tissue: lymph node
Culture conditions: Short Term Restimulated
Reference: B Nag; D Passmore; S V Deshpande; B R Clark. "In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment." Journal of immunology (Baltimore, Md. : 1950) (1992).

Epitope: MBP (1-14)A4
Chemical type: Peptide, no natural source
Sequence: ASQARPSQRHGSKY
Assay category: MhcBinding
Result: Positive

Epitope: MBP (1-14)A4
Chemical type: Peptide, no natural source
Sequence: ASQARPSQRHGSKY
Assay category: MhcBinding
Result: Positive

Epitope: MBP (1-14)A4
Chemical type: Peptide, no natural source
Sequence: ASQARPSQRHGSKY
Assay category: MhcBinding
Result: Positive

Epitope: MBP (88-101)Y88
Chemical type: Peptide, no natural source
Sequence: YFKNIVTPRTPPP
Assay category: MhcBinding
Result: Positive

Epitope: MBP (88-101)Y88
Chemical type: Peptide, no natural source
Sequence: YFKNIVTPRTPPP
Assay category: MhcBinding
Result: Positive

Epitope: MBP (88-101)Y88
Chemical type: Peptide, no natural source
Sequence: YFKNIVTPRTPPP
Assay category: MhcBinding
Result: Positive-Low

Epitope: OVA (323-340)Y340
Chemical type: Peptide, no natural source
Sequence: ISQAVHAAHAEINEAGRY
Assay category: MhcBinding
Result: Positive-Low

Epitope: OVA (323-340)Y340
Chemical type: Peptide, no natural source
Sequence: ISQAVHAAHAEINEAGRY
Assay category: MhcBinding
Result: Positive-Low

Epitope: OVA (323-340)Y340
Chemical type: Peptide, no natural source
Sequence: ISQAVHAAHAEINEAGRY
Assay category: MhcBinding
Result: Positive

Epitope: PLP (138-151)Y138
Chemical type: Peptide, no natural source
Sequence: YTSLGKWLGHPDKF
Assay category: MhcBinding
Result: Positive-Low

Epitope: PLP (138-151)Y138
Chemical type: Peptide, no natural source
Sequence: YTSLGKWLGHPDKF
Assay category: MhcBinding
Result: Positive
Reference: Xuelian Wang; Alessandro D Santin; Stefania Bellone; Sushil Gupta; Mayumi Nakagawa. "A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells." Cancer immunology, immunotherapy : CII (2009).

Epitope: HPV 16 E7 58-68
Chemical type: Peptide from protein
Sequence: CCKCDSTLRLC
Position: 58-68
Source molecule (GenBank): AAB70738.1
Assay category: TCell
Result: Positive
Host: F 
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Bruce Huang; Chih-Ping Mao; Shiwen Peng; Liangmei He; Chien-Fu Hung; T-C Wu. "Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency." Vaccine (2007).

Epitope: HPV-16 E6(49-57)
Chemical type: Peptide from protein
Sequence: VYDFAFRDL
Position: 49-57
Source molecule (GenBank): P03126
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV-16 E6(49-57)
Chemical type: Peptide from protein
Sequence: VYDFAFRDL
Position: 49-57
Source molecule (GenBank): P03126
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: HPV-16 E6(49-57)
Chemical type: Peptide from protein
Sequence: VYDFAFRDL
Position: 49-57
Source molecule (GenBank): P03126
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Culture conditions: In Vivo
Reference: Nadja Thönes; Martin Müller. "Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes." Virology (2007).

Epitope: L1 165-173
Chemical type: Peptide from protein
Sequence: AGVDNRECI
Position: 165-173
Source molecule (GenBank): ACG75893.1
Assay category: TCell
Result: Positive
Host:  6-8 weeks
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Diane M Da Silva; Steven C Fausch; J Sjef Verbeek; W Martin Kast. "Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity." Journal of immunology (Baltimore, Md. : 1950) (2007).

Epitope: HPV 16E7 <sub>(49-57)</sub>
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 5-6 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV 16E7 <sub>(49-57)</sub>
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 5-6 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV 16E7 <sub>(49-57)</sub>
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 5-6 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV 16E7 <sub>(49-57)</sub>
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 5-6 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 L1<sub>(165-173)</sub>
Chemical type: Peptide from protein
Sequence: AGVDNRECI
Position: 165-173
Source molecule (GenBank): ACG75893.1
Assay category: TCell
Result: Positive
Host: F 5-6 weeks
Cell type: T cell
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: HPV16 L1<sub>(165-173)</sub>
Chemical type: Peptide from protein
Sequence: AGVDNRECI
Position: 165-173
Source molecule (GenBank): ACG75893.1
Assay category: TCell
Result: Positive
Host: F 5-6 weeks
Cell type: T cell
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: HPV 16 E7 <sub>(30-67)</sub>
Chemical type: Peptide from protein
Sequence: DSSEEEDEIDGPAGQAEPDRAHYNIVTFCCKCDSTLRL
Position: 30-67
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 5-6 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Sharmal Narayan; Allison Choyce; Germain J P Fernando; Graham R Leggatt. "Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity." European journal of immunology (2007).

Epitope: HPV16 E7(49-57) GF001
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host:  6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Cell Line / Clone
Reference: Katharina Slupetzky; Ratish Gambhira; Timothy D Culp; Saeed Shafti-Keramat; Christina Schellenbacher; Neil D Christensen; Richard B S Roden; Reinhard Kirnbauer. "A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11." Vaccine (2007).

Epitope: HPV16-L2 69-81
Chemical type: Peptide from protein
Sequence: RTGYIPLGTRPPT
Position: 69-81
Source molecule (GenBank): ACL12316.1
Assay category: BCell
Result: Positive

Epitope: HPV16-L2 69-81
Chemical type: Peptide from protein
Sequence: RTGYIPLGTRPPT
Position: 69-81
Source molecule (GenBank): ACL12316.1
Assay category: BCell
Result: Positive

Epitope: HPV16-L2 69-81
Chemical type: Peptide from protein
Sequence: RTGYIPLGTRPPT
Position: 69-81
Source molecule (GenBank): ACL12316.1
Assay category: BCell
Result: Positive

Epitope: HPV16-L2 69-81
Chemical type: Peptide from protein
Sequence: RTGYIPLGTRPPT
Position: 69-81
Source molecule (GenBank): ACL12316.1
Assay category: BCell
Result: Positive

Epitope: L2 108-120
Chemical type: Peptide from protein
Sequence: LVEETSFIDAGAP
Position: 108-120
Source molecule (GenBank): ACL12316.1
Assay category: BCell
Result: Positive

Epitope: L2 108-120
Chemical type: Peptide from protein
Sequence: LVEETSFIDAGAP
Position: 108-120
Source molecule (GenBank): ACL12316.1
Assay category: BCell
Result: Positive

Epitope: L2 108-120
Chemical type: Peptide from protein
Sequence: LVEETSFIDAGAP
Position: 108-120
Source molecule (GenBank): ACL12316.1
Assay category: BCell
Result: Positive

Epitope: L2 108-120
Chemical type: Peptide from protein
Sequence: LVEETSFIDAGAP
Position: 108-120
Source molecule (GenBank): ACL12316.1
Assay category: BCell
Result: Positive

Epitope: BPV1 L1epitope
Chemical type: Peptide from protein
Sequence: DTYRYI
Position: 414-419
Source molecule (GenBank): P03103.1
Assay category: BCell
Result: Positive
Host: F 6 weeks
Reference: Pallavi R Manuri; Bharti Nehete; Pramod N Nehete; Rose Reisenauer; Seth Wardell; Amy N Courtney; Ratish Gambhira; Dakshyani Lomada; Ashok K Chopra; K Jagannadha Sastry. "Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection." Vaccine (2007).

Epitope: E7<sup>44-62</sup>
Chemical type: Peptide from protein
Sequence: QAEPDRAHYNIVTFCCKCD
Position: 44-62
Source molecule (GenBank): AAB70738.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: E7<sup>44-62</sup>
Chemical type: Peptide from protein
Sequence: QAEPDRAHYNIVTFCCKCD
Position: 44-62
Source molecule (GenBank): AAB70738.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: E6<sup>42-57</sup>
Chemical type: Peptide from protein
Sequence: QLLRREVYDFAFRDL
Position: 43-57
Source molecule (GenBank): P03126
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: E6<sup>42-57</sup>
Chemical type: Peptide from protein
Sequence: QLLRREVYDFAFRDL
Position: 43-57
Source molecule (GenBank): P03126
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: E7<sup>49-57</sup>
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): AAB70738.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: E6<sup>49-58</sup>
Chemical type: Peptide from protein
Sequence: VYDFAFRDLC
Position: 49-58
Source molecule (GenBank): P03126
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Jiahua Qian; Yujun Dong; Yuk-Ying S Pang; Ramy Ibrahim; Jay A Berzofsky; John T Schiller; Samir N Khleif. "Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice." International journal of cancer. Journal international du cancer (2006).

Epitope: HPV16 E2 (69-77)
Chemical type: Peptide from protein
Sequence: ALQAIELQL
Position: 69-77
Source molecule (GenBank): P03120.1
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E2 (69-77)
Chemical type: Peptide from protein
Sequence: ALQAIELQL
Position: 69-77
Source molecule (GenBank): P03120.1
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E2 (69-77)
Chemical type: Peptide from protein
Sequence: ALQAIELQL
Position: 69-77
Source molecule (GenBank): P03120.1
Assay category: MhcBinding
Result: Positive

Epitope: HPV16 E2 (138-147)
Chemical type: Peptide from protein
Sequence: YICEEASVTV
Position: 138-147
Source molecule (GenBank): P03120.1
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E2 (138-147)
Chemical type: Peptide from protein
Sequence: YICEEASVTV
Position: 138-147
Source molecule (GenBank): P03120.1
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E2 (138-147)
Chemical type: Peptide from protein
Sequence: YICEEASVTV
Position: 138-147
Source molecule (GenBank): P03120.1
Assay category: MhcBinding
Result: Positive

Epitope: HPV16 E2 (93-101)
Chemical type: Peptide from protein
Sequence: TLQDVSLEV
Position: 93-101
Source molecule (GenBank): P03120.1
Assay category: TCell
Result: Negative
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E2 (93-101)
Chemical type: Peptide from protein
Sequence: TLQDVSLEV
Position: 93-101
Source molecule (GenBank): P03120.1
Assay category: MhcBinding
Result: Negative

Epitope: HPV16 E2 (7-16)
Chemical type: Peptide from protein
Sequence: RLNVCQDKIL
Position: 7-16
Source molecule (GenBank): P03120.1
Assay category: MhcBinding
Result: Negative

Epitope: HPV16 E7 (49-57)
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (49-57)
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: S Peng; C Trimble; L He; Y-C Tsai; C-T Lin; D A K Boyd; D Pardoll; C-F Hung; T-C Wu. "Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice." Gene therapy (2006).

Epitope: HPV16 E7 (11-20)
Chemical type: Peptide from protein
Sequence: YMLDLQPETT
Position: 11-20
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive-Low
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (11-20)
Chemical type: Peptide from protein
Sequence: YMLDLQPETT
Position: 11-20
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (49-57)
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (49-57)
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (86-93)
Chemical type: Peptide from protein
Sequence: TLGIVCPI
Position: 86-93
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Negative
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (86-93)
Chemical type: Peptide from protein
Sequence: TLGIVCPI
Position: 86-93
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Negative
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (82-90)
Chemical type: Peptide from protein
Sequence: LLMGTLGIV
Position: 82-90
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Negative
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Pirouz Daftarian; Marc Mansour; Anita C Benoit; Bill Pohajdak; David W Hoskin; Robert G Brown; W Martin Kast. "Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion." Vaccine (2006).

Epitope: HPV16 E7 (49-57) R9F
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: HPV16 E7 (49-57) R9F
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (49-57) R9F
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (49-57) R9F
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HPV16 E7 (49-57) R9F
Chemical type: Peptide from protein
Sequence: RAHYNIVTF
Position: 49-57
Source molecule (GenBank): ABL96585.1
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Reference: Kevin H Kim; Ryan Dishongh; Alessandro D Santin; Martin J Cannon; Stefania Bellone; Mayumi Nakagawa. "Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone." Cancer immunity (2006).

Epitope: HPV-39 E6 47-56
Chemical type: Peptide from protein
Sequence: FAFSDLYVVY
Position: 47-56
Source molecule (GenBank): P24835.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: HPV-73 E6 45-54
Chemical type: Peptide from protein
Sequence: FAFSDLCIVY
Position: 46-55
Source molecule (GenBank): CAA63882.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: HPV-45 E6 47-56
Chemical type: Peptide from protein
Sequence: FAFKDLCIVY
Position: 47-56
Source molecule (GenBank): P21735.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: HPV-51 E6 45-54
Chemical type: Peptide from protein
Sequence: VAFTEIKIVY
Position: 45-54
Source molecule (GenBank): P26554.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: HPV-35 E6 45-54
Chemical type: Peptide from protein
Sequence: FACYDLCIVY
Position: 45-54
Source molecule (GenBank): ACV53993.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone